These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16705398)

  • 1. CT appearance of incidental pancreatic lipomas: a case series.
    Hois EL; Hibbeln JF; Sclamberg JS
    Abdom Imaging; 2006; 31(3):332-8. PubMed ID: 16705398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipomas of the pancreas.
    Katz DS; Nardi PM; Hines J; Barckhausen R; Math KR; Fruauff AA; Lane MJ
    AJR Am J Roentgenol; 1998 Jun; 170(6):1485-7. PubMed ID: 9609158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental pancreatic lipomas: computed tomography imaging findings with emphasis on diagnostic challenges.
    Temizoz O; Genchellac H; Unlu E; Kantarci F; Umit H; Demir MK
    Can Assoc Radiol J; 2010 Jun; 61(3):156-61. PubMed ID: 20350800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomographic and magnetic resonance imaging findings of asymptomatic intra-abdominal gastrointestinal system lipomas.
    Genchellac H; Demir MK; Ozdemir H; Unlu E; Temizoz O
    J Comput Assist Tomogr; 2008; 32(6):841-7. PubMed ID: 19204441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsuspected fluorodeoxyglucose positron emission tomography (FDG-PET)-positive pancreatic lesions: prevalence and significance.
    Pitts A; Nissen NN; Waxman A; Yu R
    Pancreas; 2013 Oct; 42(7):1191-3. PubMed ID: 24048460
    [No Abstract]   [Full Text] [Related]  

  • 6. Intrapancreatic lipoma: first case diagnosed with CT.
    Di Maggio EM; Solcia M; Dore R; Preda L; La Fianza A; Rodino C; Campani R
    AJR Am J Roentgenol; 1996 Jul; 167(1):56-7. PubMed ID: 8659420
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diffuse intestinal lipomatosis associated with pancreatic and adrenal lipomas. Diagnosis with computerized tomography: the first case?].
    Rossi A; Rossi G
    Radiol Med; 1998 Dec; 96(6):636-8. PubMed ID: 10189935
    [No Abstract]   [Full Text] [Related]  

  • 10. [The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions].
    Voth M; Opfermann T; Gottschild D
    Zentralbl Chir; 2003 May; 128(5):375-8. PubMed ID: 12813634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intrapancreatic lipoma: a rare mesenquimatous tumor with an uncertain physiopathogenesis].
    Lozano Samaniego A; Kimura Fujikami Y; Criales Vera S; Stoopen Rometti M
    Gac Med Mex; 2011; 147(5):429-31. PubMed ID: 22089677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron-emission tomography and computed tomography of cystic pancreatic masses.
    Tann M; Sandrasegaran K; Jennings SG; Skandarajah A; McHenry L; Schmidt CM
    Clin Radiol; 2007 Aug; 62(8):745-51. PubMed ID: 17604762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of positron emission tomography and CT in evaluating pancreatic tumors: technical and clinical implications.
    Kalra MK; Maher MM; Boland GW; Saini S; Fischman AJ
    AJR Am J Roentgenol; 2003 Aug; 181(2):387-93. PubMed ID: 12876016
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT).
    Cameron K; Golan S; Simpson W; Peti S; Roayaie S; Labow D; Kostakoglu L
    Abdom Imaging; 2011 Aug; 36(4):463-71. PubMed ID: 21465110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
    Buchs NC; Bühler L; Bucher P; Willi JP; Frossard JL; Roth AD; Addeo P; Rosset A; Terraz S; Becker CD; Ratib O; Morel P
    J Gastroenterol Hepatol; 2011 Apr; 26(4):657-62. PubMed ID: 21155879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT diagnosis of pancreatic lipoma: a case report and Literature review.
    Magenta Biasina A; Curti A; Bonifacio C; Soldi S; Cornalba GP
    Radiol Med; 2002 Oct; 104(4):367-9. PubMed ID: 12569319
    [No Abstract]   [Full Text] [Related]  

  • 17. False-positive findings on 18F-FDG PET/CT: differentiation of hibernoma and malignant fatty tumor on the basis of fluctuating standardized uptake values.
    Smith CS; Teruya-Feldstein J; Caravelli JF; Yeung HW
    AJR Am J Roentgenol; 2008 Apr; 190(4):1091-6. PubMed ID: 18356460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [X-ray computed tomography of duodenal lipoma].
    Maradji-Melia P; Bruneton JN; Balu-Maestro C; Dubruque F; Marcy PY; Rogopoulos A; Mourou MY
    J Radiol; 1992; 73(6-7):395-8. PubMed ID: 1474513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elastofibroma dorsi incidentally detected by (18)F-FDG PET/CT imaging.
    Erhamamci S; Reyhan M; Nursal GN; Torun N; Yapar AF; Findikcioglu A; Canpolat T
    Ann Nucl Med; 2015 Jun; 29(5):420-5. PubMed ID: 25666569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rare Case of Giant Intraperitoneal Lipoma Found Incidentally on
    Ibáñez MJ; Reyes RH; Frutos L; Claver MA
    J Nucl Med Technol; 2019 Jun; 47(2):173-174. PubMed ID: 31019037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.